[ad_1]
© Reuters.
Authors: Scott Murdoch and Wu Kane
Hong Kong (Reuters)-According to three sources with direct knowledge of the matter, the Chinese medical data group LinkDoc Technology Ltd has shelved its US listing plan to raise up to US$211 million after restrictions on overseas listings in Beijing.
LinkDoc, described as a provider of medical data solutions in China, applied for an initial public offering (IPO) in the US last month and will price its shares after the US market closes on Thursday.
The move came after Beijing said on Tuesday that it would strengthen supervision of all Chinese companies listed overseas. This comprehensive regulatory shift triggered a sell-off of Chinese stocks listed in the United States.
Since the information has not yet been made public, the source declined to be named.
LinkDoc, based in Beijing, did not immediately respond to a request for comment.
Converged Media Fusion Media or anyone related to Fusion Media will not be liable for any loss or damage caused by relying on the data, quotations, charts, and buy/sell signals contained in this website. Please fully understand the risks and costs associated with financial market transactions. This is one of the most risky forms of investment.
[ad_2]
Source link
